The study’s outcomes paved the way for the ongoing Phase III study. Credit: Andrei_R via Shutterstock. The US Food and Drug ...

BostonGene has secured top honors in five categories in the 2024 Pharmaceutical Excellence Awards – Business Expansion, ...

A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the ...

AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

Dizal has submitted sunvozertinib’s new drug application (NDA) to the US Food and Drug Administration (FDA) aiming to secure ...

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

We explore the immense potential of gamma delta T cells, and the challenges in sourcing and scaling up sufficient volumes to ...

Analysis of future trends highlights that the cold chain logistics sector is at a critical juncture, with tech advancements driving change.

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.